Anders Krarup-Hansen

Anders Krarup-Hansen

Clinical Associate Professor

Member of:

  • Clinical Oncology


Publication year:
All
1 - 1 out of 1Page size: 10
  1. 2014
  2. Published

    Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

    Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schöffski, P., Blay, J., Kerst, J. M., Sufliarsky, J., Whelan, J., Hohenberger, P., Krarup-Hansen, Anders, Alcindor, T., Marreaud, S., Litière, S., Hermans, C., Fisher, C., Hogendoorn, P. C. W., dei Tos, A. P., van der Graaf, W. T. A. & European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, E. O. A. T. O. C. S. T. A. B. S. G., Apr 2014, In: Lancet Oncology. 15, 4, p. 415-423 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 925763